Efficacy and Safety of Combination Therapy With Immune Checkpoint Inhibitors and Chemotherapy With Gemcitabine and Nab‐Paclitaxel in Pancreatic Cancer: A Systematic Review

Documenti analoghi

• Efficacy and Safety Evaluation of Immune Checkpoint Inhibitors in Combination With Chemotherapy for Extensive Small Cell Lung Cancer: Real‐World Evidence
  di: Yuta Yamanaka, et al.
  Pubblicazione: (2024)
• Efficacy and Safety of Immune Checkpoint Inhibitors in the Treatment of Hematologic Malignancies: An Umbrella Review of Systematic Reviews and Meta‐Analyses
  di: Zhengyu Yu, et al.
  Pubblicazione: (2026)
• Real‐World Efficacy of Nab‐Paclitaxel Plus Capecitabine and a PD ‐1 Inhibitor in Metastatic or Locally Advanced Esophageal Cancer
  di: Yun Wang, et al.
  Pubblicazione: (2026)
• Phase I Trial of Upamostat Combined With Gemcitabine in Locally Unresectable or Metastatic Pancreatic Cancer: Safety and Preliminary Efficacy Assessment
  di: Xiuping Lai, et al.
  Pubblicazione: (2024)
• The Addition of Concurrent Immune Checkpoint Inhibitors for Chemoradiotherapy With Consolidative Immune Checkpoint Inhibitors in Unresectable Cancers: A Systematic Review and Meta‐Analysis
  di: Xu Tong, et al.
  Pubblicazione: (2026)